MMS

MMS has big news to kick off 2025! We are proud to announce that we have acquired Exploristics | Transforming Clinical Trial Design a leading biostatistics and data science company based in Belfast, Northern Ireland. This is a major milestone for MMS as we integrate Exploristics' advanced statistics and biometrics expertise and their flagship technology product, KerusCloud, into our award-winning suite of solutions. Together, we are strengthening our global capabilities in statistical analysis and advanced simulation, combined with our deep regulatory know-how, to better serve Sponsors and accelerate the delivery of life-changing therapies. Please join us in welcoming the Exploristics team to the #OneMMS family in the comments! Read the full details here: https://hubs.li/Q036mPqH0 #Acquisition #Biostatistics #ClinicalTrials #KerusCloud #LifeSciences #DataScience #Simulation #DrugDevelopment

Did you know that we help sponsors navigate the complexities of pharmacovigilance and risk management with data-driven insights, regulatory expertise, and end-to-end support? We do! Our approach to Safety & Risk Management includes: ✅ Pharmacovigilance & Safety Surveillance – Monitoring and analyzing safety data to detect and mitigate risks early. ✅ Regulatory Strategy & Compliance – Ensuring compliance with global safety regulations, including FDA, EMA, and MHRA. ✅ Risk Management Plans (RMPs) & REMS – Developing and optimizing strategies to protect patients while accelerating approvals. ✅ Aggregate Safety Reporting – Efficient and compliant Periodic Benefit-Risk Evaluation Reports (PBRERs), DSURs, and PSURs. ✅ Medical Writing for Safety – High-quality safety narratives and documentation to meet global standards. With an experienced team of MDs, PhDs, and regulatory experts, we provide strategic solutions to enhance drug safety, minimize risks, and ensure compliance across global markets. Learn more at https://hubs.li/Q03cSsjB0. What’s your biggest challenge in pharmacovigilance? Let’s discuss in the comments or email us at [email protected]! 👇 #DrugSafety #Pharmacovigilance #RiskManagement #ClinicalResearch

Thank you to BioSpace, and others, for publishing our recent REMS news! "The integration of proprietary REMS-focused technology applications, with longstanding expertise in regulatory affairs and a commitment to advancing patient safety, establishes MMS as a leading REMS provider in the space." Read the full details at https://lnkd.in/gYU8aEVV #REMS #Pharma #OneMMS

With our recent growth and expansion in Europe, MMS will have a booth at this year’s Society for Clinical Data Management (SCDM) EMEA 2025 conference in Brussels, Belgium next month! MMS leaders Doreen Van Huyssteen, Salih (Sal) Siam and Minya Engelbrecht will be exploring the latest advancements in data integrity, automation, and regulatory compliance. Visit our booth onsite to connect with our experts, learn how MMS is driving innovation in clinical data management, and explore solutions that enhance efficiency and compliance in clinical trials. 💡 Learn more: https://hubs.li/Q03cGSGq0 💡 Find out about our offerings: https://hubs.li/Q03cGPz10 #SCDM2025 #ClinicalData #DataManagement #RegulatoryCompliance

Today, MMS colleagues are live at the REMS Industry Consortium Annual Meeting, where industry leaders are coming together to discuss the future of Risk Evaluation and Mitigation Strategies (REMS) and our full-service REMS solutions! Don’t miss MMS CEO Dr. Uma Sharma’s talk on the latest innovations shaping REMS programs and how regulatory science can enhance patient safety and compliance today at 12:40pm. If you’re attending, we’d love to connect! Email us at [email protected] to schedule a time or read our latest perspectives on REMS here: https://hubs.li/Q03c1hPX0 What are the biggest challenges and opportunities you see in REMS programs? Let’s discuss in the comments! 👇 #REMS #RegulatoryScience #PatientSafety #Pharma #Biotech #RiskManagement

We’re Live at PHUSE US Connect 2025! 📢 Join us today for our session on “Ensuring Data Integrity: A Three-Step Approach to Clinical Dashboard Validation.” 🚀 Visit Booth 4 to connect with our experts, enter our daily prize draw, and explore how MMS is advancing data integrity to support your clinical development goals. 🔗 Learn more about our Full-service Biometrics solutions: https://lnkd.in/gvFcNdv6 #PHUSEUSConnect #ClinicalData #DataIntegrity #Datascience

Wishing our connections a day filled with joy, luck, and a touch of Irish charm. Here’s to embracing tradition, celebrating community, and sharing a bit of kindness wherever you go. Lá Fhéile Pádraig sona duit! 💚 #StPatricksDay #GoodFortune

The PHUSE US Connect 2025 event kicks off today! We’re on the ground in Orlando, FL for an exciting week of discussions, innovation, and collaboration in clinical data science. Be sure to catch our session tomorrow on “Ensuring Data Integrity: A Three-Step Approach to Clinical Dashboard Validation,” and stop by booth 4 to connect with our team, enter our daily prize draw, learn how we’re advancing data integrity, and explore how MMS can support your clinical development goals. Who’s here at PHUSE US Connect? Let us know in the comments! 👇 Details on our full-service biometrics solutions are available here: https://lnkd.in/gvFcNdv6 #PHUSEUSConnect #ClinicalData #DataIntegrity #Biostatistics

Happy Holi from our team to yours! Today, our Bangalore and Hyderabad teams came together to celebrate the festival of colors, and what a vibrant day it was! From splashes of color to sharing the traditional thandai, the energy was pure joy. At MMS, our people are at the heart of everything we do. Moments like these remind us of the power of community and connection that make us #OneMMS. This celebration is a reminder that when we come together, we're spreading happiness, unity, and bright beginnings to create something truly colorful in work and life! #Holi #TeamCulture #India

Patient safety is at the heart of everything we do! To us, it is part of our commitment to upholding the highest standards in clinical research, regulatory strategy, and drug development to ensure safe and effective treatments reach those who need them most. We prioritize patient safety through: ✅ Robust clinical trial design, ensuring protocols minimize risk and maximize data integrity. ✅ Regulatory expertise to navigate evolving global safety standards with precision. ✅ Pharmacovigilance and risk management, by identifying and mitigating potential safety concerns early. ✅ Transparency and compliance, by supporting full disclosure and ethical research practices. As we work alongside sponsors, regulators, and research teams, our goal remains clear: to advance science while protecting and prioritizing patients at every step. What are your top priorities in patient safety? Join the conversation in the comments! 👇 #PatientSafetyAwarenessWeek #ClinicalResearch #Pharmacovigilance #DrugSafety #OneMMS